@article{ref1,
title="Homegrown perceptions about the medical use and potential abuse of CBD and THC",
journal="Addictive behaviors",
year="2020",
author="McFadden, Brandon R. and Malone, Trey",
volume="115",
number="",
pages="e106799-e106799",
abstract="Despite heightened consumer interest in cannabinoids such as cannabidiol (CBD) and tetrahydrocannabinol (THC), little is known about public perceptions regarding their  medical use and potential for abuse, particularly relative to commonly used  medications. Using data from 1,050 U.S. adult respondents from a national survey  conducted in 2019, this study found that more than half of respondents perceived  CBD, THC, hemp, and marijuana as having medical use. They also perceived the  potential for abuse of CBD, THC, hemp, and marijuana as significantly less than  potential for abuse of commonly prescribed anti-anxiety and pain medications. At the  nexus of medical use and potential abuse, public perceptions classified CBD and hemp  as similar to over-the-counter pain relief medications such as Advil and Tylenol and  did not classify marijuana as a Schedule I substance. Slightly more than 20% of  respondents reported having consumed CBD and/or THC. CBD was consumed more than THC  to reduce pain while THC was consumed more than CBD for recreation. There were no  differences in the types of medications they were replacing with CBD and THC.<p /> <p>Language: en</p>",
language="en",
issn="0306-4603",
doi="10.1016/j.addbeh.2020.106799",
url="http://dx.doi.org/10.1016/j.addbeh.2020.106799"
}